Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid

NCT01896895 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Bilateral Blepharospasm (BEB)

Interventions

DRUG: IncobulinumtoxinA (Xeomin), 25 Units
DRUG: IncobotulinumtoxinA (Xeomin), 12.5 Units
DRUG: Placebo
DRUG: IncobotulinumtoxinA (Xeomin), 35 Units

Sponsor

Merz Pharmaceuticals GmbH